22nd Century Group (NASDAQ:XXII) Receives Sell (E+) Rating from Weiss Ratings

Weiss Ratings reiterated their sell (e+) rating on shares of 22nd Century Group (NASDAQ:XXII) in a research report released on Saturday morning,Weiss Ratings reports.

Separately, StockNews.com downgraded shares of 22nd Century Group from a “hold” rating to a “sell” rating in a research note on Tuesday, December 31st.

22nd Century Group Stock Performance

Shares of NASDAQ:XXII opened at $1.71 on Friday. The company has a market cap of $2.94 million, a price-to-earnings ratio of 0.00 and a beta of 1.67. The company has a 50-day moving average price of $3.40 and a 200-day moving average price of $12.53. The company has a current ratio of 1.09, a quick ratio of 0.93 and a debt-to-equity ratio of 1.59. 22nd Century Group has a 12 month low of $1.68 and a 12 month high of $581.85.

Hedge Funds Weigh In On 22nd Century Group

A hedge fund recently bought a new stake in 22nd Century Group stock. Anson Funds Management LP purchased a new stake in shares of 22nd Century Group, Inc. (NASDAQ:XXII) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned 6.77% of 22nd Century Group at the end of the most recent reporting period. Hedge funds and other institutional investors own 18.06% of the company’s stock.

About 22nd Century Group

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.